Muscular Dystrophy

Home » DEPLOYMENT PROCESS » DEPLOYMENT PROTOCOLS » Muscular Dystrophy

Muscular Dystrophy (MD) is a disease characterized by progressive skeletal muscle weakness, defects in muscle proteins (dystrophin concentration is greatly reduced), and the death of muscle cells and tissue. Diagnosis is based on muscle biopsy, laboratory evaluation (increased levels of creatine phosphokinase) and EMG findings. There are nine major types of MD and most types of MD are multi-system disorders with manifestations in body systems including the heart, gastrointestinal system, nervous system, endocrine glands, eyes and brain. MD has a strong genetic link. Treatment options are limited. There has been a keen interest in using stem cells to regenerate muscle tissue and there has been success in using human stem cells for MD in mice. There is hope that adipose derived stem cells may be effective in regenerating muscle damaged by MD.

CAROLINA STEM CELL TREATMENT CENTER AND CSN have developed a specific SVF deployment protocol that attempts to utilize the potential regenerative properties of SVF (rich in mesenchymal stem cells and growth factors). SVF is systemically deployed and is expected to hone to damaged areas preferentially. This is all done as an outpatient at the time of SVF harvesting and procurement. The entire cellular surgical procedure takes approximately three hours.

Muscular Dystrophy Call to Action

We care about our Muscular Dystrophy patients at Carolina Stem Cell Treatment Center an affiliate of CSN. We take pride in the time we provide to our patients to deploy the best protocols to help our patients achieve their goals. By filling out the CSCTC Confidential Candidate Application, we will answer the questions and concerns you may have about CSCTC and CSN protocols for Muscular Dystrophy.